The Clorox Company (NYSE:CLX) Holdings Trimmed by Insight Advisors LLC PA

Insight Advisors LLC PA trimmed its position in shares of The Clorox Company (NYSE:CLX) by 5.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,797 shares of the company’s stock after selling 227 shares during the period. Insight Advisors LLC PA’s holdings in Clorox were worth $613,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CLX. Mizuho Securities USA LLC boosted its stake in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP lifted its stake in shares of Clorox by 512.7% in the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after purchasing an additional 453,624 shares during the last quarter. International Assets Investment Management LLC lifted its stake in shares of Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after purchasing an additional 435,971 shares during the last quarter. Boston Trust Walden Corp lifted its stake in shares of Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after purchasing an additional 268,966 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CLX shares. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Price Performance

Shares of Clorox stock opened at $145.98 on Thursday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $18.07 billion, a price-to-earnings ratio of 50.86, a P/E/G ratio of 2.92 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The firm’s 50-day moving average price is $162.25 and its two-hundred day moving average price is $158.76.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the previous year, the business earned $2.16 EPS. On average, equities analysts predict that The Clorox Company will post 6.86 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.34%. Clorox’s payout ratio is 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.